Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery (Free4Flow)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Following surgery to remove tumours of the head and neck, patients undergo reconstruction with free flaps - tissue that is taken from elsewhere in the body and given a new blood supply by attaching it to vessels in the neck. Following this type of surgery, patients often need medication to maintain their blood pressure in the intensive care unit. The effect of these drugs on the transplanted tissues is unknown. This study investigates the effects of four commonly used drugs on free flap perfusion.
| Condition | Intervention | Phase |
|---|---|---|
|
Oral Cancer Head and Neck Cancer Free Flap Hypotension |
Drug: Epinephrine Drug: Norepinephrine Drug: Dobutamine Drug: Dopexamine |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | An Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery: A Randomised Study |
- Absolute change in transfer function (flap vascular resistance) after pressor infusion. [ Time Frame: Post infusion (at 4 hours) ] [ Designated as safety issue: No ]
- Relative change in transfer function after pressor infusion compared with "normal" tissue. [ Time Frame: Post infusion (at 4 hours) ] [ Designated as safety issue: No ]
- Change in flap flow after pressor infusion [ Time Frame: Post infusion (at 4 hours) ] [ Designated as safety issue: No ]
- Differences in frequency spectrum of skin blood flow between flaps and "normal" tissue before and after pressor infusion. [ Time Frame: Post infusion (at 4 hours) ] [ Designated as safety issue: No ]
| Enrollment: | 25 |
| Study Start Date: | October 2008 |
| Study Completion Date: | February 2010 |
| Primary Completion Date: | February 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Pressors
Epinephrine, Norepinephrine, Dobutamine, Dopexamine
|
Drug: Epinephrine
0.2mcg/kg/min maximum infusion; to increase mean arterial pressure by 30mmHg
Drug: Norepinephrine
Maximum infusion of 0.2mcg/kg/min, to increase mean arterial pressure by 30mmHg
Drug: Dobutamine
Maximum infusion rate of 8mcg/kg/min to increase mean arterial pressure by 30mmHg
Drug: Dopexamine
Maximum infusion rate of 5mcg/kg/min to increase mean arterial pressure by 30mmHg
|
Detailed Description:
The optimal sympathomimetic drug to support blood pressure without adverse vasoconstriction of free flap circulation remains unknown. This study examined the effects of four agents (epinephrine, norepinephrine, dobutamine and dopexamine) on free flaps following resection of head and neck cancer.
Twenty five patients were recruited to the study. Each patient received an infusion of the four drugs in a random order with an intervening washout period between drugs, at four infusion rates. Continuous free flap skin blood flow monitoring was performed using laser Doppler velocimetry, with a second sensor on normal skin acting as a control. Global cardiovascular variables were monitored using the LiDCO Rapid pulse contour analysis system.
Eligibility| Ages Eligible for Study: | 17 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients undergoing free tissue transfer surgery at the John Radcliffe Hospital wih planned post-operative admission to the intensive care unit.
Exclusion Criteria:
- Pregnancy
- Weight >100kg
- Contraindications to pressor infusions
- Overnight ventilation not indicated
Contacts and Locations| United Kingdom | |
| John Radcliffe Hospital | |
| Oxford, Oxfordshire, United Kingdom, OX3 9DU | |
| Principal Investigator: | Stephen R Watt-Smith, FDSRCS, MD | Oxford University Hospitals NHS Trust |
More Information
No publications provided by Oxford University Hospitals NHS Trust
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Mr SR Watt-Smith, Oxford Radcliffe Hospitals NHS Trust |
| ClinicalTrials.gov Identifier: | NCT01418118 History of Changes |
| Other Study ID Numbers: | 2008-000073-37 5579, 2008 000073 37, 08/H0606/31 |
| Study First Received: | August 15, 2011 |
| Last Updated: | August 15, 2011 |
| Health Authority: | United Kingdom: Medicines and Healthcare Products Regulatory Agency United Kingdom: National Health Service United Kingdom: Research Ethics Committee |
Keywords provided by Oxford University Hospitals NHS Trust:
|
noradrenaline norepinephrine epinephrine adrenaline dobutamine dopexamine inotrope |
pressor sympathomimetic free flap transplantation free tissue transfer microsurgery survival |
Additional relevant MeSH terms:
|
Head and Neck Neoplasms Hypotension Mouth Neoplasms Neoplasms by Site Neoplasms Vascular Diseases Cardiovascular Diseases Mouth Diseases Stomatognathic Diseases Epinephrine Dobutamine Dopexamine Norepinephrine Epinephryl borate Adrenergic beta-Agonists |
Adrenergic Agonists Adrenergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Pharmacologic Actions Physiological Effects of Drugs Bronchodilator Agents Autonomic Agents Peripheral Nervous System Agents Anti-Asthmatic Agents Respiratory System Agents Therapeutic Uses Mydriatics Adrenergic alpha-Agonists Sympathomimetics |
ClinicalTrials.gov processed this record on May 19, 2013